Institute of Biochemistry, Center for Structural and Cell Biology in Medicine, University of Lübeck, Lübeck, Germany.
J Virol. 2012 Apr;86(8):4444-54. doi: 10.1128/JVI.06635-11. Epub 2012 Feb 8.
Nonstructural proteins 7 and 8 of severe acute respiratory syndrome coronavirus (SARS-CoV) have previously been shown by X-ray crystallography to form an 8:8 hexadecamer. In addition, it has been demonstrated that N-terminally His(6)-tagged SARS-CoV Nsp8 is a primase able to synthesize RNA oligonucleotides with a length of up to 6 nucleotides. We present here the 2.6-Å crystal structure of the feline coronavirus (FCoV) Nsp7:Nsp8 complex, which is a 2:1 heterotrimer containing two copies of the α-helical Nsp7 with conformational differences between them, and one copy of Nsp8 that consists of an α/β domain and a long-α-helix domain. The same stoichiometry is found for the Nsp7:Nsp8 complex in solution, as demonstrated by chemical cross-linking, size exclusion chromatography, and small-angle X-ray scattering. Furthermore, we show that FCoV Nsp8, like its SARS-CoV counterpart, is able to synthesize short oligoribonucleotides of up to 6 nucleotides in length when carrying an N-terminal His(6) tag. Remarkably, the same protein harboring the sequence GPLG instead of the His(6) tag at its N terminus exhibits a substantially increased, primer-independent RNA polymerase activity. Upon addition of Nsp7, the RNA polymerase activity is further enhanced so that RNA up to template length (67 nucleotides) can be synthesized. Further, we show that the unprocessed intermediate polyprotein Nsp7-10 of human coronavirus (HCoV) 229E is also capable of synthesizing oligoribonucleotides up to a chain length of six. These results indicate that in case of FCoV as well as of HCoV 229E, the formation of a hexadecameric Nsp7:Nsp8 complex is not necessary for RNA polymerase activity. Further, the FCoV Nsp7:Nsp8 complex functions as a noncanonical RNA polymerase capable of synthesizing RNA of up to template length.
严重急性呼吸综合征冠状病毒(SARS-CoV)的非结构蛋白 7 和 8 通过 X 射线晶体学显示形成 8:8 十六聚体。此外,已经证明 N 端带有 His(6)标签的 SARS-CoV Nsp8 是一种能够合成长度达 6 个核苷酸的 RNA 寡核苷酸的引物。我们在此介绍猫冠状病毒(FCoV)Nsp7:Nsp8 复合物的 2.6-Å 晶体结构,它是一种 2:1 的异三聚体,包含两个具有构象差异的α-螺旋 Nsp7 拷贝,以及一个由α/β结构域和长α-螺旋结构域组成的 Nsp8 拷贝。通过化学交联、凝胶过滤层析和小角 X 射线散射证明,该复合物在溶液中的化学计量比也是如此。此外,我们还表明,FCoV Nsp8 与 SARS-CoV 相对应,当携带 N 端 His(6)标签时,能够合成长度达 6 个核苷酸的短寡核糖核苷酸。值得注意的是,与 N 端的 His(6)标签序列相比,同一个蛋白的 GPLG 序列可以显著提高依赖引物的 RNA 聚合酶活性。加入 Nsp7 后,RNA 聚合酶活性进一步增强,从而可以合成长达模板长度(67 个核苷酸)的 RNA。此外,我们还表明,人冠状病毒(HCoV)229E 的未加工中间多蛋白 Nsp7-10 也能够合成长度达 6 个核苷酸的寡核糖核苷酸。这些结果表明,对于 FCoV 以及 HCoV 229E 来说,形成十六聚体 Nsp7:Nsp8 复合物对于 RNA 聚合酶活性不是必需的。此外,FCoV Nsp7:Nsp8 复合物作为一种非典型的 RNA 聚合酶,能够合成长达模板长度的 RNA。